Adhesions are a formidable challenge in patients undergoing reoperative cardiac surgery, particularly in those supported by an intracorporeal left ventricular assist device (LVAD) and undergoing heart transplantation. This report describes the pathological findings following the clinical use of a surgical sealant (CoSeal, Baxter Healthcare, Fremont, CA), in a patient who underwent LVAD implantation. On the treated surfaces, a minimal amount of adhesions were observed, whereas in untreated surfaces adhesions were present.
CannataATaglieriCRussoCFBruschiGMartinelliL. Use of CoSeal in a patient with a left ventricular assist device. Ann Thorac Surg. 2009;87:1956-1958.
2.
LeakLVFerransVJCohenSREidboEEJonesM. Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: ultrastructural studies. Am J Anat. 1987;180:373-390.
3.
Pace NapoleoneCValoriACrupiG. An observational study of CoSeal for the prevention of adhesions in pediatric cardiac surgery. Interact Cardiovasc Thorac Surg. 2009;9:978-982.
4.
NaitoYShin’okaTHibinoNMatsumuraGKurosawaH. A novel method to reduce pericardial adhesion: a combination technique with hyaluronic acid biocompatible membrane. J Thorac Cardiovasc Surg. 2008;135: 850-866.
5.
KaushalSPatelSKGohSKSoodAWalkerBLBackerCL. A novel combination of bioresorbable polymeric film and expanded polytetrafluoroethylene provides a protective barrier and reduces adhesions. J Thorac Cardiovasc Surg. 2011;141:789-795.
